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We aim to determine the incidence of early myocardial dysfunction after out-of-hospital cardiac
arrest, risk factors associated with its development, and association with outcome. A retrospective
chart review was performed among consecutive out-of-hospital cardiac arrest (OHCA) patients
who underwent echocardiography within 24 h of return of spontaneous circulation at three urban
teaching hospitals. Our primary outcome is early myocardial dysfunction, defined as a left
ventricular ejection fraction < 40% on initial echocardiogram. We also determine risk factors
associated with myocardial dysfunction using multivariate analysis, and examine its association
with survival and neurologic outcome. A total of 190 patients achieved ROSC and underwent
echocardiography within 24 h. Of these, 83 (44%) patients had myocardial dysfunction. A total of
37 (45%) patients with myocardial dysfunction survived to discharge, 39% with intact neurologic
status. History of congestive heart failure (OR 6.21; 95% CI 2.54–15.19), male gender (OR 2.27;
95% CI 1.08–4.78), witnessed arrest (OR 4.20; 95% CI 1.78–9.93), more than three doses of
epinephrine (OR 6.10; 95% CI 1.12–33.14), more than four defibrillations (OR 4.7; 95% CI 1.35–
16.43), longer duration of resuscitation (OR 1.06; 95% CI 1.01–1.10), and therapeutic
hypothermia (OR 3.93; 95% CI 1.32–11.75) were associated with myocardial dysfunction.
Cardiopulmonary resuscitation immediately initiated by healthcare personnel was associated with
lower odds of myocardial dysfunction (OR 0.40; 95% CI 0.17–0.97). There was no association
between early myocardial dysfunction and mortality or neurological outcome. Nearly half of
OHCA patients have myocardial dysfunction. A number of clinical factors are associated with

Compliance with ethical standards
Conflict of interest The authors declare that they have no competing interests.
Statement of human and animal rights This study was approved by the Institutional Review Board at the University of
Pennsylvania.
Informed consent For this type of study, informed consent is not required.

Yao et al.

Page 2

Author Manuscript

myocardial dysfunction, and may aid providers in anticipating which patients need early
diagnostic evaluation and specific treatments. Early myocardial dysfunction is not associated with
neurologically intact survival.

Keywords
Cardiac arrest; Out-of-hospital; Myocardial dysfunction; Echocardiography; Neurological
outcome

Introduction
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Out-of-hospital cardiac arrest (OHCA) presents a considerable health burden in the United
States, with an estimated incidence of 300,000 persons each year [1, 2]. Even though return
of spontaneous circulation (ROSC) is achieved in 30–40% of OHCA patients, only 7% of
patients receiving CPR will survive to hospital discharge, with significant geographic
variability [1, 2].

Author Manuscript

Post-cardiac arrest syndrome (PCAS) is a complex constellation of multi-organ failure
comprised of brain injury, systemic ischemia–reperfusion response, and post-cardiac arrest
myocardial dysfunction, which contributes significantly to morbidity after cardiac arrest [2,
3]. Myocardial dysfunction is an important cause of post-resuscitation circulatory failure
that may lead to early mortality after ROSC [3, 4]. It is defined as reversible global
dysfunction due to stunned myocardium in the absence of coronary occlusion [5–8].
Although post-cardiac arrest myocardial dysfunction is a potentially treatable complication,
the severity and duration of the myocardial dysfunction may be associated with outcome [3,
4, 7].
We aim to evaluate the incidence of post-cardiac arrest myocardial dysfunction, factors
associated with its development, and its impact on outcome. Theoretically, factors that
amplify ischemia–reperfusion injury should be associated with the presence and severity of
post-arrest myocardial dysfunction. Therefore, we hypothesize that there would be an
association between pre-hospital factors, including medical history, witnessed cardiac arrest,
initial rhythm, bystander cardiopulmonary resuscitation (CPR), number of defibrillations,
cumulative doses of epinephrine administrated during resuscitation, total downtime, and
development of myocardial dysfunction after resuscitation.

Methods
Author Manuscript

Study design
We performed a retrospective data analysis utilizing the Penn Alliance for Therapeutic
Hypothermia (PATH) database. PATH is an internet-based registry focusing on post-arrest
care, which is hosted by the University of Pennsylvania.
In this study, consecutive OHCA patients treated in three urban teaching hospitals between
May 2005 and December 2011 were screened for inclusion. Patients were included in this
study if they were over the age of 17, suffered a non-traumatic arrest, achieved ROSC, and
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had a documented echocardiogram performed within 24 h of their cardiac arrest. Exclusion
criteria included the initiation of extracorporeal life support or a preexisting “Do Not
Resuscitate” order. Research utilizing data in PATH was approved by the University of
Pennsylvania Institutional Review Board with a waiver of informed consent.
Data collection

Author Manuscript

Patient demographics, cardiac arrest characteristics, details regarding prehospital and
emergency department care, as well as patient outcomes were obtained from the PATH
registry [9, 10]. Each patient record in PATH consists of 30 data elements required for
quality assurance purposes from all participating institutions, and 100 additional data
elements are required for research participation. Data were collected retrospectively at each
of the participating institutions and entered into PATH via a secure, password-protected
internet portal by a trained healthcare provider. Before entering data, these clinicians are first
trained by the PATH database manager using a structured approach including mock case
entry and case review. All participants are provided with a standardized data dictionary for
PATH data elements and frequent telephone contact is made with each data abstracter early
in registry participation. Additionally, a formal auditing process is conducted on a selection
of cases to ensure data integrity, with feedback given to site abstractors for correction. The
database manager has access to all entered records from each participating hospital.
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Additional chart review was performed at three PATH institutions to obtain echocardiogram
results, which were not available in the PATH registry. Transthoracic or transesophageal
echocardiogram data were abstracted from clinical echocardiography reports interpreted by
attending cardiologists by a single physician-abstractor who was trained by the principal
investigator prior to the study. If there was more than one echocardiogram performed within
24 h, the final one performed within the initial 24 h period was used for analysis. The
principal investigator met regularly with the data abstractor to review abstracted charts and
ensure data quality. The initial 30 charts were also reviewed by the principal investigator to
ensure data quality and appropriate categorization. A kappa statistic was not calculated
because agreement on left ventricular ejection fraction values was 100%. The abstractor was
not blinded to the study hypothesis, but was blinded to patient outcomes.
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The most readily available quantitative measure of myocardial function is the left ventricular
ejection fraction (LVEF). According to 2010 Heart Failure Society of America guidelines,
preserved LVEF is variably defined [11]. The American Heart Association (AHA) suggests
that LVEF < 40% may indicate heart failure or cardiomyopathy while an LVEF between 40
and 55% implies damage [12]. Accordingly, myocardial dysfunction is defined as LVEF <
40% in this study, and is the variable of interest.
Outcome measures
Our primary outcome is post-cardiac arrest myocardial dysfunction. Secondary outcomes
include survival to hospital discharge with favorable neurological outcome. Neurological
outcome is measured using the cerebral performance category (CPC) score and
dichotomized into favorable versus poor outcome. Favorable neurological outcome is
defined as CPC score of 1 or 2 at hospital discharge.
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Descriptive statistics are used to summarize subject characteristics including median and
interquartile range (IQR) for continuous variables, and number (n) and percentage (%) for
categorical variables. We use Wilcoxon rank-sum test for continuous variables in univariate
comparison and Chi-square tests for categorical variables. Multivariate logistic regression is
then completed to adjust for variables influencing LVEF. Regression results are reported as
odds ratios (ORs) with 95% confidence intervals (CI). Statistical analysis was performed
using STATA 11.0 software (STATA 11.0, Statacorp, College Station, TX, USA).

Results
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Between May 2005 and December 2011, 302 patients with OHCA successfully achieved
ROSC and were transported to one of the three study hospitals. Nine patients (3%) were
excluded because of major trauma as the cause of cardiac arrest (Fig.1). Median age in the
cohort of patients with echocardiography performed within the study window is 60 years
(IQR 48, 70) and 53% are male (Table 1). The majority of the cohort is black (56%). Most
patients had a cardiac etiology for their arrests (78%) and a nonshockable rhythm (66%),
and fewer than half received bystander CPR (47%) (Table 2). Echocardiography was
performed in 221 patients (75%) and 190 (86%) of those patients had an echocardiogram
performed within 24 after ROSC. A total of 83 patients (44%) had myocardial dysfunction
within 24 h after ROSC. There is no difference in the median time from ROSC to
echocardiogram when comparing patients with and without myocardial dysfunction (5.3 vs.
7.1 h, p = 0.18).
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When comparing patients with and without myocardial dysfunction, there is no difference in
survival or favorable neurologic outcome. Men are more likely than women to have
myocardial dysfunction (65 vs. 35%, p = 0.003) (Table 1). Duration of resuscitation is
significantly longer in patients with myocardial dysfunction (25 vs. 20 min, p = 0.002).
Patients who have myocardial dysfunction are more likely to have a history of congestive
heart failure (CHF) (63 vs. 38%, p = 0.002) or coronary artery disease (34 vs. 17%, p =
0.007). Finally, an OHCA event involving more than four defibrillations is more common in
the myocardial dysfunction group (64 vs. 36%, p = 0.001).
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In multivariate analysis, a number of factors are associated with myocardial dysfunction,
including history of CHF, male gender, witnessed arrest, more than three doses of
epinephrine, more than four defibrillations, longer duration of resuscitation, and therapeutic
hypothermia (Fig. 2). CPR immediately initiated by health professional personnel is
associated with better myocardial function. In addition, there is a significant interaction
between duration of resuscitation and more than three doses of epinephrine used during
resuscitation (OR 0.95; 95% CI 0.9–1.0).
Bystander CPR, immediate CPR from a healthcare professional, witnessed arrest, and
shockable rhythm are associated with favorable neurologic outcome on multivariable
analysis (Fig. 3). Advanced age, administration of epinephrine during resuscitation and
longer duration of resuscitation are associated with poor outcome. There is no association
between early myocardial dysfunction and neurological outcome.
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Discussion
We perform a cohort study of 190 patients after out-of-hospital cardiac arrest to examine
predictors of post-arrest myocardial dysfunction and its association with outcome. We find
associations between the following variables and myocardial dysfunction: male gender,
history of CHF, witnessed arrest, longer duration of resuscitation, more than three doses of
epinephrine, more than four defibrillations, and therapeutic hypothermia. CPR immediately
initiated by a health professional is associated with a better LVEF. Mortality and
neurological outcome are not significantly different when comparing patients with and
without myocardial dysfunction.

Author Manuscript

Classically, post-cardiac arrest myocardial dysfunction is a transient global dysfunction that
starts within minutes of arrest, becomes clinically apparent around 7 h after ROSC, and
potentially recovers fully within 48–72 h [4, 5, 7, 8, 13, 14]. Our results confirm findings
from previous studies that initial post-arrest myocardial dysfunction is not associated with
neurologic outcome [4, 14].

Author Manuscript

Few studies have looked at clinical factors associated with post-arrest myocardial
dysfunction. A previous study assessing hemodynamics in OHCA survivors reports that the
amount of epinephrine used during CPR is associated with post-arrest instability, but not
neurologic outcome [4]. Another study reports high doses of epinephrine as an independent
predictor of post-resuscitation myocardial dysfunction, but demonstrates no association with
neurologic outcome [14]. We find that a high epinephrine dose during CPR, as well as the
duration of resuscitation, is associated with post-arrest myocardial dysfunction, and that
there is an interaction between these two variables. Catecholamine excess has been
described as a cause of myocardial dysfunction in other disease states, such as stressinduced cardiomyopathy and subarachnoid hemorrhage [15, 16]. Because epinephrine dose
and duration of resuscitation are tightly associated, it is difficult to determine if this is truly a
pharmacologic effect, or simply related to prolonged ischemia and amplified reperfusion
after ROSC.
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We also find that repeated defibrillation is associated with myocardial dysfunction. The
adverse effect of repeated defibrillation on myocardial function has been reported in
laboratory studies [7, 8, 17–19]. The mechanism is not well understood, but may be related
to increased intra-myocardial temperature causing myocardial damage, potentiated
excitation–contraction uncoupling, dose-dependent release of free radicals, and waveformspecific effects on mitochondrial function [20]. This finding, along with high doses of
epinephrine and longer duration of resuscitation, suggests that individuals who develop postcardiac arrest myocardial dysfunction may have had more difficult, intervention-intensive
resuscitative efforts prior to ROSC. It is also possible that both epinephrine dose and
repeated defibrillation attempts are simply markers for prolonged resuscitation, which has
itself been associated with post-arrest myocardial dysfunction.
In this study, we also compare predictors of neurological outcomes to those of post-cardiac
arrest myocardial dysfunction. We find that factors traditionally associated with better
neurological outcome may not reliably predict preserved myocardial function. Witnessed
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cardiac arrest, as an independent predictor of favorable neurological outcome in multiple
studies, is associated with myocardial dysfunction in our study [21]. Prior investigators
demonstrate that patients with a cardiac etiology for their arrest are more likely to be
witnessed, and have a higher prevalence of pre-existing cardiovascular disease, including
congestive heart failure, previous myocardial infarction, angina pectoris, and hypertension
[22]. In our study, there is a trend toward an increased prevalence of cardiac etiology among
patients with witnessed arrest when compared with patients whose arrest was not witnessed
(81 vs. 72%), but this did not reach statistical significance. It is possible that because more
patients with witnessed arrest have a primary cardiac etiology or pre-existing cardiovascular
disease, they are more likely to develop post-arrest myocardial dysfunction.
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We also demonstrate that the use of therapeutic hypothermia (TH) is associated with
myocardial dysfunction. The association between TH and myocardial function is complex,
and should be interpreted cautiously. Therapeutic hypothermia as part of a standardized
treatment for comatose survivors of cardiac arrest is recommended by the AHA due to its
beneficial effect on both survival and neurological outcomes, but its effect on postresuscitation myocardial function remains unclear [23]. One study documents moderately
reduced myocardial function among OHCA patients at the time of admission that increases
upon induction of TH [24]. Animal models show that moderate TH preserves myocardial
function, stabilizes hemodynamics, and decreases myocardial damage; others have not
demonstrated such effects [25–30]. A sub-analysis of a recent, large randomized trial
demonstrates a decrease in cardiac index in patients treated with TH at 33 °C compared with
36 °C that is entirely attributable to heart rate; myocardial systolic function is not different
between the groups [31]. In our study, one possible explanation for the association between
TH and myocardial function is that patients who receive TH are different from those who do
not. A total of 11 patients did not receive TH because they regained sufficient neurologic
function shortly after ROSC; these patients will generally fare better than comatose patients
with regard to neurologic outcome, survival, and, likely, myocardial function. In fact, only
three of these patients had documented myocardial dysfunction.
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Post-cardiac arrest myocardial dysfunction is a common component of PCAS, which can
lead to early death [4, 32, 33]. In a recent large randomized trial, 46% of patients who died
did so before thorough neurologic prognostication could occur because of a cardiac or
hemodynamic cause [34]. These findings reinforce the need for early, aggressive
hemodynamic evaluation and support. In a small pilot study, our group shows that early
goal-directed hemodynamic optimization combined with TH is feasible and is associated
with improved outcomes when compared to historical controls [35]. Other authors have
suggested that every patient admitted to the ICU after ROSC should be screened for postcardiac arrest myocardial dysfunction because of its significant treatment implications, and
because it can be easily identified with appropriate monitoring tools [36]. Echocardiography is a safe, widely available, and relatively inexpensive clinical tool, which can
provide both anatomical and functional information. The AHA guideline for post-cardiac
arrest care suggests performing echocardiographic evaluation within 24 h to help guide
therapeutic decisions [23]. It is possible that patients with risk factors for post-arrest
myocardial dysfunction, as identified in this manuscript, might benefit from even more
aggressive, earlier screening and early treatment [36–38]
Intern Emerg Med. Author manuscript; available in PMC 2018 August 01.
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Limitations
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This study has several limitations. Because this is a retrospective cohort registry study, the
quality of data mainly relies on the accuracy of existing documentation, which may be
incomplete or incorrect. We define myocardial dysfunction according to left ventricular
function, so it is possible that patient with other forms of myocardial dysfunction, namely
right ventricular dysfunction, were missed. Another factor is the limited availability of
documentation of pre-arrest myocardial function in these individuals, which precludes the
ability to account for baseline myocardial dysfunction. It is possible that some patients may
have already had a low LVEF before their arrest. One study finds that LVEF decreases
approximately 25% among in-hospital cardiac arrest survivors within 72 h regardless of their
LVEF before cardiac arrest [37]. Importantly, we adjusted for a history of CHF in the
multivariate analysis to control for a potential difference in baseline function. We also were
unable to obtain follow up echocardiograms on all patients, so we could not demonstrate
whether post-cardiac arrest myocardial dysfunction is transient or sustained. All patients in
this study were treated at tertiary centers with comprehensive post-arrest care. Finally,
selection bias may exist because patients who have echocardiographic evaluation after
resuscitation may be significantly different from those who do not.

Conclusions
In survivors of out-of-hospital cardiac arrest, myocardial dysfunction is common in the early
post-resuscitation phase. In our study, early myocardial dysfunction is not associated with
survival or neurologic outcome. Systematic screening for post-arrest myocardial dysfunction
should be considered to improve knowledge of this potentially dangerous sequela, and
provide evidence to direct future management of these patients.
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Fig. 1.

Flow diagram of patient enrollment, exclusions, and outcomes. OHCA out of hospital
cardiac arrest, ROSC return of spontaneous circulation, Echo echocardiography, LVEF left
ventricular ejection fraction
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Fig. 2.

Factors significantly associated with myocardial dysfunction within 24 h post-arrest
(multivariable analysis). Odds ratio > 1 indicates increased likelihood of myocardial
dysfunction and odds ratio < 1 indicates decreased likelihood. CHF congestive heart failure,
CPR cardiopulmonary resuscitation, mins minutes, CI confidence interval
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Fig. 3.

Factors significantly associated favorable neurological outcome after out of hospital cardiac
arrest (multivariable analysis). Odds ratio > 1 indicates increased likelihood of myocardial
dysfunction and odds ratio < 1 indicates decreased likelihood. Favorable neurological
outcome is defined as Cerebral Performance Category score of 1 or 2. CHF congestive heart
failure, CPR cardiopulmonary resuscitation, mins minutes, CI confidence interval
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Table 1

Author Manuscript

Demographic characteristics and co-morbidities
All patients (n = 190)

LVEF < 40% (n = 83)

LVEF ≥ 40% (n = 107)

101 (53)

55 (65)

46 (43)

Gender, n (%)

p value
0.003

Male
Female

90 (47)

29 (35)

61 (57)

60 (48, 70)

60 (48, 70)

60 (48, 71)

Black

105 (56)

48 (58)

57 (54)

White

72 (38)

31 (38)

41 (39)

Other

11 (6)

3 (4)

8 (7)

Previous CHF

48 (25)

30 (36)

18 (17)

Coronary artery disease

46 (24)

28 (33)

18 (17)

0.003

Previous MI

22 (12)

12 (14)

10 (9)

0.008

Hypertension

94 (49)

35 (42)

59 (55)

0.288

Arrhythmia

6 (14)

12 (14)

14 (13)

0.064

Diabetes mellitus

65 (34)

24 (29)

41 (38)

0.81

Stroke

14 (7)

6 (7)

8 (7)

0.158

Renal insufficiency

35 (18)

14 (17)

21 (20)

0.93

Age, median (IQR), years
Race, n (%)

0.811
0.22

Preexisting conditions, n (%)
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LVEF left ventricular ejection fraction, CHF congestive heart failure, MI myocardial infarct, IQR interquar-tile range
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Table 2
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Out-of-hospital cardiac arrest event characteristics and post-arrest care
All patients (n = 190)

LVEF < 40% (n = 83)

LVEF ≥ 40% (n = 107)

Cardiac etiology

p valuea
0.088

Yes

148 (78)

69 (84)

79 (74)

No

41 (22)

13 (16)

28 (26)

Yes

130 (68)

62 (74)

68 (64)

No

61 (32)

22 (26)

39 (36)

Witnessed event

0.131

Location

0.266

Health care facility

58 (30)

22 (26)

36 (34)

Non-healthcare facility

133 (70)

62 (74)

71 (66)

Bystander

41 (21)

21 (25)

20 (19)

Health Professional

61 (32)

21 (25)

40 (37)

No

89 (47)

42 (50)

47 (44)

Shockable

65 (34)

34 (40)

31 (29)

Non-shockable

126 (66)

50 (60)

76 (71)

CPR

0.173
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First pulseless rhythm, n (%)

0.079

Number of defibrillations

0.016

No

81 (45)

28 (36)

53 (52)

1–4

48 (27)

20 (26)

28 (28)

>4

50 (28)

30 (38)

20 (20)

Epinephrine

0.17
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No dose

47 (25)

16 (19)

31 (29)

1–3 doses

74 (39)

31 (38)

43 (40)

> 3 doses

68 (36)

30 (43)

33 (31)

21 (13,41)

25 (18, 47)

20 (10, 34)

Yes

160 (84)

75 (89)

85 (79)

No

31 (16)

9 (11)

22 (21)

6.25 (3.80, 11.38)

5.28 (3.18, 13.25)

7.07 (4.1, 11.22)

Duration of resuscitation, median (IQR), min
Hypothermia

0.001
0.067

Duration of ROSC to echo median (IQR), h

0.198

LVEF left ventricular ejection fraction, CPR cardiopulmonary resuscitation, IQR interquartile range, ROSC return of spontaneous circulation, Echo
echocardiography
a

Comparing patients with LVEF LVEF < 40% to those with LVEF ≥ 40%
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